Point72 Asia Singapore Pte. Ltd. trimmed its holdings in Brookline Bancorp, Inc. (NASDAQ:BRKL – Free Report) by 45.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,620 shares of the bank’s stock after selling 3,041 shares during the quarter. Point72 Asia Singapore Pte. Ltd.’s holdings in Brookline Bancorp were worth $30,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also bought and sold shares of the company. ProShare Advisors LLC increased its stake in Brookline Bancorp by 7.4% during the 1st quarter. ProShare Advisors LLC now owns 17,640 shares of the bank’s stock valued at $176,000 after purchasing an additional 1,223 shares in the last quarter. Hennion & Walsh Asset Management Inc. increased its stake in Brookline Bancorp by 4.2% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 52,099 shares of the bank’s stock valued at $435,000 after purchasing an additional 2,097 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Brookline Bancorp by 4.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 74,413 shares of the bank’s stock valued at $742,000 after purchasing an additional 3,040 shares in the last quarter. Sei Investments Co. increased its stake in Brookline Bancorp by 7.1% during the 2nd quarter. Sei Investments Co. now owns 51,037 shares of the bank’s stock valued at $426,000 after purchasing an additional 3,397 shares in the last quarter. Finally, EntryPoint Capital LLC bought a new stake in Brookline Bancorp during the 1st quarter valued at about $47,000. 78.91% of the stock is currently owned by institutional investors.
Brookline Bancorp Stock Performance
Shares of NASDAQ BRKL opened at $9.78 on Wednesday. The firm’s 50-day moving average price is $9.99 and its 200-day moving average price is $9.32. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.19. The company has a market cap of $869.39 million, a PE ratio of 10.52 and a beta of 0.78. Brookline Bancorp, Inc. has a 52-week low of $7.93 and a 52-week high of $11.52.
Brookline Bancorp Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Friday, August 16th were issued a dividend of $0.135 per share. This represents a $0.54 dividend on an annualized basis and a dividend yield of 5.52%. The ex-dividend date was Friday, August 16th. Brookline Bancorp’s payout ratio is presently 58.06%.
Analysts Set New Price Targets
Separately, Keefe, Bruyette & Woods raised their price objective on shares of Brookline Bancorp from $10.50 to $11.00 and gave the company a “market perform” rating in a research note on Friday, July 26th.
Read Our Latest Stock Report on BRKL
Brookline Bancorp Company Profile
Brookline Bancorp, Inc operates as a bank holding company for the Brookline Bank that provide commercial, business, and retail banking services to corporate, municipal, and retail customers in the United States. Its deposit products include demand checking, NOW, money market, and savings accounts. The company’s loan portfolio primarily comprises first mortgage loans secured by commercial, multi-family, and residential real estate properties; loans to business entities comprising commercial lines of credit; loans to condominium associations; loans and leases used to finance equipment for small businesses; financing for construction and development projects; and home equity and other consumer loans.
See Also
- Five stocks we like better than Brookline Bancorp
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Why Are Stock Sectors Important to Successful Investing?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Are the FAANG Stocks and Are They Good Investments?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Brookline Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brookline Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.